• 제목/요약/키워드: toxicity symptom

검색결과 79건 처리시간 0.025초

이산화질소 가스에 의한 무화과 나무의 피해 양상 (The Toxicity of Nitrogen Dioxide Gas on Fig Plant)

  • 김유학;최병렬;김명숙
    • 한국토양비료학회지
    • /
    • 제43권6호
    • /
    • pp.978-980
    • /
    • 2010
  • This study was conducted to observe the cause of injury of fig plant. Nitrogen dioxide gas can be evolved at low pH or reduced in soil. Fig plant cultivated with nutrient solution was wilted or withered. Injury symptom for nutrient solution containing nitrous acid was worse as pH of soil decreased. However, increase in pH of nutrient solution treated with increasing $Ca(OH)_2$ solution prevented nutrient solution from producing nitrogen dioxide gas. Recovery of the fig plant by pH increase indicated that the cause of injury was nitrogen dioxide gas.

랫드와 마우스에서 소성장 호르몬-서방형 제형(BST-SR)의 급성독성에 관한 연구 (Acute Toxicity of Bovine Somatotrophine-Sustained Release(BST-SR) in Rats and Mice)

  • 강경선;이영순
    • 한국식품위생안전성학회지
    • /
    • 제6권3호
    • /
    • pp.185-189
    • /
    • 1991
  • BST-SR의 마우스 (ICR)와 랫드(S.D)에서의 급성 피하 독성을 조사하기 위하여, 본 시험 물질을 암수 각각 소에서 임상용량인 500mg/600kg의 일정한 공비로 최고 1000배 까지의 용량으로 경배부위로 1회 피하투여하여 1주일간 관찰하였으나 일반적으로 임상증상에서 아무런 이상을 발견할수 없었으며, 체중변화나 전 생존 동물의 부검에서도 아무런 이상을 발견할 수 없었다. BST-SR의 시험물질은 소에서의 임상적용 용량 1000배 까지의 투여로도 아무런 독성이 관찰되지 않은 것으로 미루어 보아 현재의 임상적용용량은 상당히 안전할 것으로 사료된다.

  • PDF

객혈 양상으로 발현된 Amiodarone 폐독성 1예 (Insidious Onset of Amiodarone Pulmonary Toxicity Presented with Hemoptysis)

  • 김헌국;정복현;한군희;황정원;조영주;박용진;정형정;김미혜;류대식;강길현
    • Tuberculosis and Respiratory Diseases
    • /
    • 제59권4호
    • /
    • pp.413-417
    • /
    • 2005
  • Amiodarone을 사용하는 환자에서 객혈이 발생하였을 경우 원인으로 amiodarone의 폐독성을 반드시 고려하여야 하며 즉시 투여를 중지하고 스테로이드를 사용하면 임상 증상을 호전시킬 수 있다. 저자들은 저용량의 amiodarone을 장기간 사용하던 환자에서 발생한 객혈을 약물 투여 중지 및 대증적 치료로 호전시킨 1예를 경험하여 문헌 고찰과 함께 보고하는 바이다.

백서에서 식품 복합물 TB001의 단회 경구투여 독성 시험 연구 (Single Oral Dose Toxicity of TB001 in Rats)

  • 차윤엽;선승호;박원형;박동식;김재현;김희연;임상현;김경희
    • 한방재활의학과학회지
    • /
    • 제21권4호
    • /
    • pp.41-47
    • /
    • 2011
  • Objectives: This study was performed to investigate single oral dose toxicity of TB001, the extract mixture of Purple loosestrife and Aceriphyllum rossii. Methods: The mortality, general symptom, change of weight: and necropcy findings was investigated for 14 days after a dose(2000 mg/kg B.W.) of TB001 was given, using SD rats of both male and female according to "The guideline of toxicity test for medicine and others". Results: The death of rats and abnormal finding was not observed. There was no the significant difference of weight between control group and TB001 group. Conclusions: The abnormalities at the necropsy finding of all survived rats was not detected. The study suggested that there is no toxicity in single dose(2000 mg/kg B.W.) of TB001.

국내육성 주요 딸기 품종에서 발생하는 붕소 과잉 증상 및 영양진단을 위한 식물체 내 한계농도 (Characterization of Toxicity Symptom and Determination of Tissue Threshold Levels of Boron for Diagnostic Criteria in Domestically Bred Strawberries)

  • 최종명;남민호;김대영
    • 원예과학기술지
    • /
    • 제30권2호
    • /
    • pp.144-151
    • /
    • 2012
  • 미량원소인 붕소(B)의 시비농도를 인위적으로 조절한 관비용액으로 '금향', '매향' 및 '설향' 딸기를 재배하면서 시비수준이 생육에 미치는 영향, 생육을 우수하게 유지할 수 있는 식물체의 한계농도, 그리고 B 과잉시비로 유발되는 생리장해의 특징을 구명하기 위하여 본 연구를 수행하였다. 0.25mM B 시비구에서 세 종류 딸기 품종의 생체중 및 건물 중이 가장 무거웠고 관부직경도 가장 굵었지만 B 시비농도가 높아짐에 지상부 생장량이 급격하게 감소하였다. B가 과다하게 시비되면 신생엽에서는 황화현상, 중간에 위치한 잎들에서는 잎 가장자리의 갈변 및 괴사현상, 그리고 하위엽들이 괴사하면서 안쪽으로 말리는 증상이 나타났다. 하위엽에서 나타나는 증상은 '금향'의 경우 2mM 이상의 처리구, '매향'과 '설향'은 0.5mM 이상의 시비구에서 잎 선단부의 갈변 및 괴사, 그리고 잎 내부에 갈변 및 괴사현상이 나타났다. B 시비농도가 증가하여도 다량원소중 양이온인 K, Ca 및 Mg 함량에는 차이가 나타나지 않았으며, 음이온인 인산 함량이 감소하는 경향을 나타냈다. B 시비농도가 증가할 때 '금향'과 '설향' 딸기에서 Fe 함량이 감소하였으며, Zn 함량이 증가하는 경향을 보였다. 건물중에 기초한 지상부 생장량의 90%와 이 때의 B 함량을 정상생육을 위한 최대한계점으로 간주할 때 '금향', '매향' 및 '설향' 딸기에서 식물체내 B 함량이 각각 25.1, 44.2 및 $62.5mg{\cdot}kg^{-1}$ 이하를 유지하도록 B 시비농도를 조절하여야 과잉피해를 방지할 수 있다고 판단하였다.

마우스, 랫트, 해명에서 집먼지 진드기 추출물의 일반 약리시험과 급성 및 아급성 독성에 관한 연구 (Genernal Pharmacological and Acute/Subacute Toxicity Test of House Dust Mite Extract in Mice, Rats, and Guinea pigs)

  • 노재열;김경환
    • Toxicological Research
    • /
    • 제14권2호
    • /
    • pp.183-191
    • /
    • 1998
  • It has been reported that 50~70% of child asthma, bronchial asthma in adult, and allergic rhinitis are caused by house dust mite. The antigen extracted from house dust mite has been used for effective treatment against allergic diseases and for clinical test. This house dust mite antigen has been entirely imported from abroad. However, the composition and content of all the antigen imported vary from a brand to other brand. Thus, we need to standardize the composition and content of the antigen by developing it domestically. We proceeded pre-clinically general pharmacological test and toxicological test that are required for the eventual human use by utilizing the house dust mite cultured in Korea. In order to obtain information on general pharmacological tests such as its toxic signs in tissues or organs which are mainly affected, we examined the effect of house dust mite on the tensions of the isolated tissues and heart rates of cardiac muscle by recording with force displacement transducer of polygragh (Glass Model 7). We determined lethality of antigen extracted from house dust mite in mice and guinea pigs. We examined acute and subacute toxicity by administrating house dust mite extract of 500, 100, 20 times of the expected clinical dose. In male and female mice and guinea pigs, given a sigle intraperitoneal dose of antigen, $LD_{50}$ values were over 5.0 $\textrm{m}{\ell}$/kg, respectively. In animals administrated with house dust mite, there were no significant change of clinical symptom, body weight, food consumption, water consumption, eye examinations, urinalysis, blood biochemistry, and histopathological examinations in any animals tested. We found no toxic effect of this house dust mite. These results show that the house dust mite cultured by us could be used in the development of medicine against allergic diseases caused by the antigen of house dust mite.

  • PDF

유전자 재조합 Human Factor VIII(GC-γ AHF)의 안전성에 관한 연구 (Safety Evaluation of Recombinant Human Factor VIII(GC-γ AHF))

  • 김민영;손장원;신민기;배미옥;김현우;최진혁;김준성;문서현;김정현
    • Toxicological Research
    • /
    • 제18권1호
    • /
    • pp.87-98
    • /
    • 2002
  • This study was conducted to evaluate the safety of a recombinant human Factor VIII(GC-$\gamma$ AHF) manufactured by Korea Green Cross Company with different technology according to the Regulation of Korean Food and Drug Administration (l 998. 12. 3). In acute toxicity test, both genders of Sprague-Dawley rats and Beagle dogs were administered intravenously with GC-$\gamma$ AHF of three doses (3,125, 625 and 125 IU/kg), and single dose of 3,125 IU/kg, respectively. No dead animal and abnormal autopsy findings were found in Control and GC-$\gamma$ AHF treated group. Therefore, the 50% lethal dose ($LD_{50}$) of GC-$\gamma$ AHF was conidered to be higher than 3,125 IU/kg in rats and dogs. In the four weeks repeated intravenous toxicity study, GC-$\gamma$ AHF was administrated intravenosly to both genders of rats and dogs with 3 doses (500, 150, 50 IU/kg). There were neither dead animals nor significant changes of body weights during the experimental Period. In addition, no significant GC-$\gamma$ AHF related changes were found in clinical sign, urinalysis and other finding. Statistically changes were observed in hematological, biochemical and organ weight parameters of treated groups: however these changes were not dose dependent. No histopathological lesion were observed in both control and treated animals. Above data suggest that no observed adverse effect level of test materials in rats and dogs might be over 500 IU/kg/day in this study. In ocular irritation test, any injury on iris, conjunctiva and cornea in rabbits were not observed. The acute ocular irritation index (A.O.I.), mean ocular irritation index (M.O.I.) and Day-7 individual ocular irritation Index (I.O.I.) of GC-$\gamma$ AHF were 0. In the primary skin Irritation test, the primary irritation index (P.I.I.) oj GC-$\gamma$ AHF were 0. Therefore, the GC-$\gamma$ AHF is considered not to have the primary skin and eye toxicity in rabbits. In active systemic anaphylaxis (ASA) test, GC-$\gamma$ AHF and GC-$\gamma$ AHF emulsified with Freund's complete adjuvant (FCA) did not induce any symptom of anaphylactic shock in guinea pigs. In passive cutaneous anaphylxis (PCA) test, after sensitization with antisera of GC-$\gamma$ AHF sensitized mice, blue spots were observed on the hypodermis of back of rats, but diameter of each spot was smaller than 5 mm in each test groups except the positive control group. Based on the results of this study, GC-$\gamma$ AHF is not conidered to have any antigenic potential. In conclusion, at levels of up to 500 IU/kg, GC-$\gamma$ AHF did not produce treatment-related toxicity under the conditions of these acute-, four week repeated-toxicity, primary skin and eye toxicity, and antigenicity test.

국내육성 주요 딸기 품종에서 발생하는 구리(Cu) 과잉 증상 및 영양진단을 위한 식물체 내 한계농도 (Characterization of Copper Toxicity Symptoms and Determination of Tissue Critical Concentration for Diagnostic Criteria in Korean Bred Strawberries)

  • 최종명;남민호
    • 원예과학기술지
    • /
    • 제30권5호
    • /
    • pp.477-483
    • /
    • 2012
  • 미량원소인 Cu 시비농도를 인위적으로 조절하여 '금향', '매향' 및 '설향' 딸기를 재배하면서 시비수준이 생장에 미치는 영향을 구명하였다. 또한 생육을 우수하게 유지할 수 있는 식물체의 Cu 한계농도를 밝혀 딸기 재배 시 영양장해를 진단할 수 있는 기초 자료로 활용될 수 있도록 하기 위하여 본 연구를 수행하였다. Cu 시비농도에 영향을 받은 세 종류 딸기 품종의 건물중에서 '금향'과 '매향'은 0.25mM-1.0mM 시비구 간, '설향' 딸기의 경우 0.25mM-3.0mM 시비구 간통계적인 유의차가 없었고, '설향'이 '금향'이나 '매향'보다 Cu 과다시비에 대한 내성이 강함을 알 수 있었다. Cu가 과다하게 시비되어 식물체의 흡수량이 증가하면 신엽에서 엽맥 간 황화현상이나 엽맥 사이에 직선형태의 황화현상이 그리고 하위엽에서는 잎 가장자리가 주황색으로 변하는 증상이 나타났다. 관비용액의 Cu 시비농도를 증가시켜도 세 종류 딸기의 식물체 내 P, K, Ca 및 Mg 함량은 뚜렷한 경향을 발견할 수 없었다. 미량원소 중 Cu 함량은 시비농도가 높아짐에 따라 식물체 내 함량이 직선적으로 증가하였으며, Fe 및 Mo 함량은 관비용액의 Cu 농도에 대한 반응이 뚜렷하지 않았고, 경향도 발견할 수 없었다. '금향', '매향' 및 '설향' 딸기의 최대생장량보다 10% 적은 생장량과 이 때의 식물체내 Cu 함량을 정상 생장을 위한 최대한계점으로 간주하면 '금향' $71.4mg{\cdot}kg^{-1}$, '매향' $57.9mg{\cdot}kg^{-1}$, 그리고 '설향' $74.81mg{\cdot}kg^{-1}$ 이하를 유지하도록 Cu 시비농도를 조절해야 한다고 판단하였다.

치매 치료제 염산 디히드로에보다이아민의 생식 및 발생 독성 (Reproduction and Development Toxicity of Anti-Alzheimer′s Drug Dehydroevodiamine-HCl)

  • 성이숙;정성윤;서영득;진미령;최봉웅;장병모;김대경
    • 약학회지
    • /
    • 제46권6호
    • /
    • pp.452-458
    • /
    • 2002
  • Dehydroevodiamine-HCl (DHED), which is a component separated from Evodia rutaecarpa Bentham, has novel anticholinesterase and antiamnesic activities in a scopolamine-induced amnesia model. Several studies suggest that DHED might be an effective drug for Alzheimer's disease and a vascular type of dementia. DHED was at dose levels of 0, 50, 100 and 200 mg/kg/day administered intraperitoneally to Sprague-Dawley male rats for 60 days before mating and to females from 14 days before mating to 7 days after mating. Effects of the DHED on general symptom and reproductive performance of parent animals and embryonic development were examined. In male parents, whereas no death was observed, reduction in the increase rate of body weight was found at 200 mg/kg. In female parents, both of the mating performance and the fertility of parent animals were decreased at 200 mg/kg, but not significantly. In 200 mg/kg treated group, the fetal death rate was increased but total fetuses showed no changes compared to the control group. There were no malformed F1 fetuses in all groups.

청혈단(淸血丹)의 임상적인 부작용에 대한 연구 (Clinical Assessment on the Safety of Chunghyul-dan (Qingwie-dan))

  • 조기호;정우상;박성욱;문상관;김영석;배형섭
    • 대한한의학회지
    • /
    • 제24권3호
    • /
    • pp.45-50
    • /
    • 2003
  • Background and Purpose : Chunghyul-dan has been widely used in the Department of Cardiovascular & Neurologic Diseases, Kyung Hee Oriental Medical Center to prevent stroke by lowering serum cholesterol level. Previous experimental and clinical studies revealed that Chunghyul-dan had therapeutic effects on hyperlipidemia by inhibiting HMG-CoA reductase and pancreatic lipase. It was also reported that Chunghyul-dan showed an anti-oxidation effect by scavenging free radicals and inhibiting nitric oxide synthesis. Therefore, we examined the safety of Chunghyul-dan on all subjects who had been treated with it. Methods : We performed a retrospective study by reviewing the medical records of those who had been administrated Chunghyul-dan at Kyung Hee Oriental Medical Center from February 8,2001 to December 31,2002. The subjects' general characteristics (gender, age, medical history, and present illness), recorded adverse effects, and the results of laboratory findings were obtained and analyzed to assess the clinical safety of Chunghyul-dan. Results : Six hundred fifty six subjects were treated with Chunghyul-dan. Clinical adverse effects appeared in 13 subjects, the major symptom being indigestion (8 subjects). The apparent frequency of adverse effects was much lower than that in previous reports on the safety of certain medications. On investigation of laboratory findings, we could not find any hepatic or renal toxicity. Conclusion : We suggest that our results contribute towards confirming the safety of Chunghyul-dan by offering clinical evidence.

  • PDF